OpenAI worked with Retro Biosciences to develop GPT-4b micro, an AI model that it says can engineer proteins capable of turning regular cells into stem cells (Antonio Regalado/MIT Technology Review)
OpenAI worked with Retro Biosciences to develop GPT-4b micro, an AI model that it says can engineer proteins capable of turning regular cells into stem cells (Antonio Regalado/MIT Technology Review)